explore -WSS

explore

author：entertainment 2025-09-27 07:51:35 - browse：18

Photo illustration with orange background of Desmond Padhi, PharmD, interim CEO, Latigo (center), with Latigo board chair Nancy Stagliano (left) and Westlake Village BioPartners founding managing director Sean Harper, M.D. (right) -- biotech coverage from STAT — Desmond Padhi, PharmD, interim CEO, Latigo (center), with Latigo board chair Nancy Stagliano (left) and Westlake Village BioPartners founding managing director Sean Harper, M.D. (right) Illustration: Christine Kao/STAT; Courtesy: Steve Shoffner & Michael Haber

After three years being incubated by California VC Westlake Village BioPartners, a new biotech launched Wednesday with $135 million and plans to compete with Vertex Pharmaceuticals.

The startup is called Latigo Biotherapeutics, and it’s launching having already started a Phase 1 trial for a non-opioid pain medicine, LTG-001. The oral therapy is designed to silence pain-signaling neurons by blocking a sodium channel called NaV 1.8.

Westlake had set out years ago to scout out new options for pain medicines, and found a research desert, according to founding managing director Sean Harper. But NaV 1.8 has emerged as a promising option because of its potential to be non-addictive and to lessen pain without affecting a person’s central nervous system, digestion, or heart rate, as opioids can. There were still few high-quality molecules in development that could be licensed from an academic lab or another drug company, so Westlake decided to develop its own.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： How to make Best Hospitals ratings actually useful for patients

hotspot

knowledge

Wikipedia

WSS

Bernie Sanders is gearing up to subpoena pharma CEOs

Investment in vaccine development is lagging, report finds

In science, is the line between industry and academia shifting?

How a symptom of dementia informs our understanding of creativity

Syphilis numbers in the United States reach record heights

Australia’s approach to dialysis celebrates life

leisure time

explore

Wikipedia

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Zyn nicotine pouches become unlikely player in latest culture war

Medical records are filled with copy

Radiation, mainstay of cancer treatment, begins a fade

Walensky prepares to leave CDC — and Congress — behind

Winners, losers from Medicare’s list of drugs subject to price talks

Cancer drug shortages should be causing more outrage

Medicare explains how it will choose drugs for negotiation

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Wegovy leads to weight loss. Can it treat depression, too?

hotspot

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Medicare drug price negotiation legal challenge met with skepticism

Pancreatic cancer early detection could be helped by AI

Biogen walks away from Aduhelm, years after polarizing approval

What AAP's gender

New clues to why women have higher risk of autoimmune disorders

hotspot

knowledge

Wikipedia

Wikipedia